Microvascular compromise remains a devastating complication following free tissue transfer. The purpose of this study is to identify preoperative risk factors and perioperative strategies predictive of successful flap salvage.
METHODS:
A retrospective chart review was conducted for all breast, head/neck, and lower extremity free flaps performed at a single-institution between [2005] [2006] [2007] [2008] [2009] [2010] [2011] [2012] [2013] [2014] [2015] . The primary endpoint, successful salvage, was defined as any flap that did not result in complete flap loss. Univariate analysis was performed using Chi-squared, Wilcoxon rank-sum, and Fisher's exact test. Lastly, a multivariate logistic regression was performed.
RESULTS:
Of the first consecutive 5,000 free flaps performed by 6 surgeons, 4,847 free flaps were analyzed. 74 take-backs for delayed microvascular compromise were identified. The overall mean take-back rate was 1.53%. Fifty flaps (67.6%) were salvaged. Factors predictive of successful salvage included: no thrombotic event during index reconstruction (OR=19.6; p=0.016) and revision of index anastomosis during take-back (OR=6.48; p=0.014). Chemical thrombectomy use (OR=12.2; p=0.096) and non-existence of thrombophilic abnormalities (OR=8.2; p=0.054) trended towards significance.
CONCLUSION:
This study represents the largest takeback series in the published literature. There is evidence to suggest that certain preoperative comorbidities and Brigham and Women's Hospital, Boston, MA PURPOSE: Breast cancer related lymphedema affects more than 400,000 survivors in the United States. In 2009, Lymphatic Microsurgical Preventing Healing Approach (LYMPHA) was first described as a surgical technique to prevent lymphedema by performing a prophylactic bypass at the time of an axillary node dissection (ALND). We describe the first animal model evaluating the efficacy of LYMPHA.
METHODS:
In Yorkshire pigs, each distal hind limb lymphatic system was cannulated and injected with a different fluorophore (human serum albumin conjugated indocyanine green (ICG-HSA) or Evans Blue (EB-HSA)). FluorescenceAssisted Resection and Exploration (FLARE) imaging was used to map the respective lymphatic systems. Lymphatic clearance of each hind limb was measured via fluorescence of each dye from centrally obtained blood samples. A lymphadenectomy (control side) versus lymphadenectomy with LYMPHA (study side) was then performed. The injections were then repeated.
RESULTS:
ICG-HSA and EB-HSA allowed for lymphatic mapping of each respective hind limb utilizing FLARE imaging. Lymphatic clearance of ICG-HSA from the distal hind limb dropped 64% when comparing no intervention versus a groin lymphadenectomy. In comparison, lymphatic clearance of EB-HSA dropped only 22% from the distal hind limb when comparing no intervention versus a lymphadenectomy with LYMPHA.
